Therapeutic Proteins & Peptides
In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information about therapeutic protein & peptide targets, technologies, pipelines and markets. The range of products covers industry data as well as in-depth strategic assessment and analysis of protein technologies, targets, product profiles, companies, R&D pipelines, deals and financing.
Showing all 8 results
- 2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA€ 130.00
- 2023 sales data of originator therapeutic proteins and antibodies, selected biosimilars and other biologic drug modalities (gene & cell therapy, RNA)€ 130.00
- Online database of annual global sales of innovator & bioimilar biologics since the year 2007€ 250.00
- This product provides basic information on immunotherapeutics on the market and in R&D targeting nectin-4€ 200.00
- This product provides basic information on approved therapeutics and therapy candidates in R&D targeting PSMA.€ 400.00
- This product provides basic information on drug candidates in research and development targeting CD40 or CD40 ligand€ 300.00
- This product provides basic information on drug & imaging candidates in R&D targeting Fibroblast Activation Protein (FAP)€ 300.00
- Landscape description and analysis of prodrug antibodies and cytokines employing conventional and novel masking technologies from an industry perspective as of October 2021€ 2250.00